Explore
Search ClinicalTrials.gov
Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.
Results for “AstraZeneca”
- Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate CancerActive Not Recruiting
Sponsor: AstraZeneca
Metastatic Prostate Cancer
United States, Australia, Italy, United Kingdom
- A Study of Acalabrutinib Plus Venetoclax and Rituximab in Participants With Treatment Naïve Mantle Cell LymphomaActive Not Recruiting
Sponsor: AstraZeneca
Mantle Cell Lymphoma (MCL)
United States, Australia, Brazil, Canada, Poland +2 more
- A Study of BR Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated MCLActive Not Recruiting
Sponsor: Acerta Pharma BV
Lymphoma, Mantle Cell
United States, Argentina, Australia, Belgium, Brazil +22 more
Sponsor: AstraZeneca
Non-small Cell Lung Cancer
China
- Observational Study Evaluate Pathology Practice Use Artificial Intelligence in Patient Suspected Lung and Breast CancerActive Not Recruiting
Sponsor: AstraZeneca
Lung Cancer · Breast Cancer
Brazil, Egypt, Kenya
- Assessment of Efficacy and Safety of Monalizumab Plus Cetuximab Compared to Placebo Plus Cetuximab in Recurrent or Metastatic Head and Neck CancerActive Not Recruiting
Sponsor: AstraZeneca
Squamous Cell Carcinoma of the Head and Neck
United States, Argentina, Australia, Austria, Belgium +18 more
Sponsor: Alexion Pharmaceuticals, Inc.
Paroxysmal Nocturnal Hemoglobinuria
China
- Study Evaluating AZD7798 for Treatment in Crohn's Disease Patients With an IleostomyActive Not Recruiting
Sponsor: AstraZeneca
Crohn's Disease
Belgium, Italy, Netherlands, Poland, Sweden +2 more
Sponsor: AstraZeneca
Real World Multi-cohort Study of Patients With Non-small Cell Lung Cancer (NSCLC) Initiating Approved Drugs Developed by AZ or as Part of an AZ Alliance
France
- A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Rosuvastatin on LDL-C in Patients With HypercholesterolaemiaNot Yet Recruiting
Sponsor: AstraZeneca
Hypercholesterolaemia
Sponsor: AstraZeneca
Unresectable Hepatocellular Carcinoma
Sponsor: American Society of Clinical Oncology
Lymphoma, Non-Hodgkin · Multiple Myeloma · Advanced Solid Tumors
United States, Puerto Rico
Sponsor: AstraZeneca
Chronic Obstructive Pulmonary Disease (COPD)
Russia
- AZD6244 (ARRY-142886) Solid Oral Dosage Formulation in Participants With Advanced Solid MalignanciesActive Not Recruiting
Sponsor: AstraZeneca
Tumor · Cancer
United States, Netherlands, United Kingdom
- National Acalabrutinib Observational StudyActive Not Recruiting
Sponsor: AstraZeneca
Chronic Lymphocytic Leukemia
France
Sponsor: AstraZeneca
Ovarian Cancer
Russia
Sponsor: AstraZeneca
Polymyositis, Dermatomyositis
United States, Argentina, Australia, Austria, Belgium +24 more
- CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in RussiaActive Not Recruiting
Sponsor: AstraZeneca
Unresectable /Inoperable Locally Advanced (Stage II-III) NSCLC and Locally Advanced LS-SCLC (Stage I-III)
Russia
Sponsor: Sarcoma Alliance for Research through Collaboration
Malignant Peripheral Nerve Sheath Tumors · Neurofibromatosis 1
United States
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Non-Small Cell Lung Cancer
United States, Canada
Sponsor: Daiichi Sankyo
Gastric Cancer, Adenocarcinoma · Gastroesophageal Junction Adenocarcinoma
Argentina, Belgium, Brazil, Chile, China +19 more
Sponsor: UNICANCER
Metastatic Breast Cancer
France
Sponsor: Amsterdam UMC, location VUmc
Breast Cancer · Metastatic Breast Cancer · HER2-positive Breast Cancer · Gastric Cancer
Netherlands
Sponsor: AstraZeneca
Chronic Kidney Disease
Spain
Sponsor: AstraZeneca
Breast Cancer · Breast Neoplasms · Colon Cancer · Colonic Cancer
United States